Improvement of Heart Function After Transplantation of Encapsulated Stem Cells Induced with miR-1/Myocd in Myocardial Infarction Model of Rat
Cardiovascular disease is one of the most common causes of death worldwide. Mesenchymal stem cells (MSCs) are one of the most common sources in cell-based therapies in heart regeneration. There are several methods to differentiate MSCs into cardiac-like cells, such as gene induction. Moreover, using...
Guardado en:
Autores principales: | Samaneh Khazaei, Masoud Soleimani, Seyed Hossein Ahmadi Tafti, Rouhollah Mehdinavaz Aghdam, Zohreh Hojati |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
SAGE Publishing
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3c0e147b13dc48c4b9c9b980926915c6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Differentiation of Mesenchymal Stem Cells Into Cardiac-like Cells by Co-induction of Lentiviruses Containing Mir-1 and Myocd in Chitosan Collagen Hydrogel Scaffold
por: Samaneh Khazaei, et al.
Publicado: (2021) -
Bioengineering of injectable encapsulated aggregates of pluripotent stem cells for therapy of myocardial infarction
por: Shuting Zhao, et al.
Publicado: (2016) -
Perioperative acute myocardial infarction in the first deceased kidney transplantation done in Bihar
por: Chandan Kumar, et al.
Publicado: (2021) -
Dual-modal tracking of transplanted mesenchymal stem cells after myocardial infarction
por: Li YF, et al.
Publicado: (2011) -
Stem cell transplantation dose in patients with acute myocardial infarction: A meta-analysis
por: Jia-Ying Xu, et al.
Publicado: (2016)